Suppr超能文献

阿托伐他汀和西地那非可降低血管紧张素转化酶 -β水平和基质金属蛋白酶 -2活性,并改善肾血管性高血压模型中的动脉重塑。

Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.

作者信息

Guimarães Danielle A, Rizzi Elen, Ceron Carla S, Martins-Oliveira Alisson, Gerlach Raquel F, Shiva Sruti, Tanus-Santos Jose E

机构信息

Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Brazil.

Department of Morphology, Estomatology and Physiology, Dental School of Ribeirao Preto, University of Sao Paulo, Brazil.

出版信息

Redox Biol. 2015 Dec;6:386-395. doi: 10.1016/j.redox.2015.08.017. Epub 2015 Aug 31.

Abstract

Imbalanced matrix metalloproteinase (MMP)-2 activity and transforming growth factor expression (TGF-β) are involved in vascular remodeling of hypertension. Atorvastatin and sildenafil exert antioxidant and pleiotropic effects that may result in cardiovascular protection. We hypothesized that atorvastatin and sildenafil alone or in association exert antiproliferative effects by down-regulating MMP-2 and TGF-β, thus reducing the vascular hypertrophy induced by two kidney, one clip (2K1C) hypertension. Sham and 2K1C rats were treated with oral atorvastatin 50 mg/kg, sildenafil 45 mg/kg, or both, daily for 8 weeks. Blood pressure was monitored weekly. Morphologic changes in the aortas were studied. TGF-β levels were determined by immunofluorescence. MMP-2 activity and expression were determined by in situ zymography, gel zymography, Western blotting, and immunofluorescence. The effects of both drugs on proliferative responses of aortic smooth muscle cells to PDGF and on on MMP-2 activity in vitro were determined. Atorvastatin, sildenafil, or both drugs exerted antiproliferative effects in vitro. All treatments attenuated 2K1C-induced hypertension and prevented the increases in the aortic cross-sectional area and media/lumen ratio in 2K1C rats. Aortas from 2K1C rats showed higher collagen deposition, TGF-β levels and MMP-2 activity and expression when compared with Sham-operated animals. Treatment with atorvastatin and/or sildenafil was associated with attenuation of 2K1C hypertension-induced increases in these pro-fibrotic factors. However, these drugs had no in vitro effects on hr-MMP-2 activity. Atorvastatin and sildenafil was associated with decreased vascular TGF-β levels and MMP-2 activity in renovascular hypertensive rats, thus ameliorating the vascular remodeling. These novel pleiotropic effects of both drugs may translate into protective effects in patients.

摘要

基质金属蛋白酶(MMP)-2活性失衡和转化生长因子表达(TGF-β)参与高血压的血管重塑。阿托伐他汀和西地那非具有抗氧化和多效性作用,可能带来心血管保护。我们假设阿托伐他汀和西地那非单独使用或联合使用可通过下调MMP-2和TGF-β发挥抗增殖作用,从而减轻两肾一夹(2K1C)高血压诱导的血管肥厚。假手术组和2K1C大鼠每日口服50 mg/kg阿托伐他汀、45 mg/kg西地那非或两者联用,持续8周。每周监测血压。研究主动脉的形态学变化。通过免疫荧光法测定TGF-β水平。通过原位酶谱法、凝胶酶谱法、蛋白质印迹法和免疫荧光法测定MMP-2活性和表达。测定两种药物对主动脉平滑肌细胞对血小板衍生生长因子(PDGF)增殖反应的影响以及对体外MMP-2活性的影响。阿托伐他汀、西地那非或两种药物联用在体外均发挥抗增殖作用。所有治疗均减轻了2K1C诱导的高血压,并预防了2K1C大鼠主动脉横截面积和中膜/管腔比值的增加。与假手术动物相比,2K1C大鼠的主动脉显示出更高的胶原沉积、TGF-β水平以及MMP-2活性和表达。阿托伐他汀和/或西地那非治疗与减轻2K1C高血压诱导的这些促纤维化因子增加有关。然而,这些药物对人重组MMP-2活性无体外影响。阿托伐他汀和西地那非与肾血管性高血压大鼠血管TGF-β水平降低和MMP-2活性降低有关,从而改善血管重塑。这两种药物的这些新的多效性作用可能转化为对患者的保护作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验